LCAHA
LCAHA (LCA hydroxyamide) is a deubiquitinase USP2a inhibitor with IC50s of 9.7 μM and 3.7μM in Ub-AMC Assay and Di-Ub Assay, respectively. LCAHA destabilizes Cyclin D1 and induces G0/G1 arrest by inhibiting deubiquitinase USP2a[1].
Product Specifications
CAS Number
117094-40-3
Product Name Alternative
LCA hydroxyamide
UNSPSC
12352211
Hazard Statement
H302, H312, H332
Target
Deubiquitinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lcaha.html
Purity
99.91
Solubility
DMSO : 45 mg/mL (ultrasonic)
Smiles
C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(NO)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4([C@](C[C@@H](CC4)O)([H])CC3)C
Molecular Formula
C24H41NO3
Molecular Weight
391.59
Precautions
H302, H312, H332
References & Citations
01
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HA723836B 100 µL
Human Fas / CD95 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
AP23139PU-N 50 µg
PDGF beta (PDGFB) (222-233) Goat Polyclonal Antibody
Sign In for Pricing
View Details 
LY423342 100 µg
Treacher Collins syndrome protein (TCOF1) (NM_001008657) Human Over-expression Lysate
Sign In for Pricing
View Details 
